Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomesMark C. Genovese, Barbara Finck, Joan M. Bathon et al.|Arthritis & Rheumatism|2002Cited by 733
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the <i>F508del-CFTR</i> mutationJohn P. Clancy, Michael W. Konstan, Raouf Amin et al.|Thorax|2011Cited by 496